Diving deep into liver abscess development
The combination of genomic and metabolic data from both bacteria and animals will provide insights into how liver abscesses develop, help identify vaccine or drug development targets, and potentially contribute to better diagnostic techniques.
Started: 2022 | Completed: 2026
Evaluating antimicrobial peptides for animal pathogens and forecasting resistance
This project is early-stage research, which if successful, outlines a methodology to discover and optimize AMPs to specific bacteria or pathogens of concern to the beef industry.
Started: 2022 | Completed: 2025
Exploring options to manage Mycoplasma bovis
While this project is very early stage drug discovery research, and will certainly not eliminate M. bovis infections immediately, it is exploring a new approach that potentially can improve the management of this bacteria in the future.
Started: 2021 | Completed: 2025
Training immunity as an alternative to antibiotics
Several different approaches are being investigated to develop effective alternatives to antimicrobial products. One potential avenue is to stimulate or “train” immune cells to react to pathogens by exposing them to related bacteria that don’t cause disease.
Started: 2023
Showing 1-12 of 50